Minnesota Rehabilitation and Reinvestment (MRRA) Engagement Project
ID: 354581Type: Posted
Overview

Buyer

National Institute of Corrections (USDOJ-BOP-NIC)

Award Range

$0 - $50K

Eligible Applicants

Others

Funding Category

Other

Funding Instrument

Cooperative Agreement

Opportunity Category

Other

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/354581
Timeline
    Description

    The National Institute of Corrections is offering a cooperative agreement for the Minnesota Rehabilitation and Reinvestment (MRRA) Engagement Project, aimed at facilitating group sessions to develop comprehensive policies associated with the MRRA. This initiative is critical for enhancing rehabilitation strategies within the correctional system, ensuring that effective policies are established through collaborative efforts. The total funding available for this project is $50,000, with one award expected to be made. Interested parties can reach out to Cameron D. Coblentz at ccoblentz@bop.gov or by phone at 202-514-0053 for further information, with applications due by June 10, 2024.

    Point(s) of Contact
    ccoblentz@bop.gov
    Files
    No associated files provided.
    Similar Opportunities
    NIJ FY24 Evaluation of BJA Byrne State Crisis Intervention Program (SCIP): Scan of Practices and Evaluability Assessments
    Active
    National Institute of Justice
    The National Institute of Justice (NIJ) is inviting proposals for the evaluation of the Bureau of Justice Assistance (BJA) Byrne State Crisis Intervention Program (SCIP) through a cooperative agreement. The objective is to examine programs funded by BJA under SCIP for Fiscal Years 2022-2024, focusing on practices related to extreme risk protection orders, court responses to individuals in crisis, community-based services, and law enforcement crisis intervention initiatives. This funding opportunity, with an estimated total program funding of $6.6 million and an award ceiling of $1.5 million per award, aims to support research in two categories: a scan of practices and evaluability assessments of the funded programs. Interested applicants must submit their proposals by November 19, 2024, and can contact the OJP Response Center at grants@ncjrs.gov for assistance.
    HEAL Initiative: JCOIN Phase II Innovation Hubs (R01 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity through the HEAL Initiative: JCOIN Phase II Innovation Hubs (R01 Clinical Trial Optional) to support research on effective interventions for individuals with substance use disorders (SUDs) within the criminal-legal system. This initiative aims to enhance the delivery of medication for opioid use disorder (MOUD) and address the overdose crisis by establishing multiple research centers that will collaborate with resource centers to improve treatment access and continuity of care for justice-involved populations. With a total funding budget of $5 million, the NIH plans to award five to seven grants, each with a maximum direct cost of $2.25 million, for projects lasting up to five years. Interested applicants must submit their proposals by January 22, 2025, and can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    Section 206 of the Consolidated Appropriations Act, 2024: State Planning Grants to Promote Continuity of Care for Medicaid and CHIP Beneficiaries Following Incarceration
    Active
    Centers for Medicare & Medicaid Services
    The Centers for Medicare & Medicaid Services (CMS) is offering planning grants under Section 206 of the Consolidated Appropriations Act, 2024, aimed at enhancing continuity of care for Medicaid and CHIP beneficiaries following incarceration. Eligible applicants, including state and territorial Medicaid and CHIP agencies, are required to collaborate if they operate separately, and must submit comprehensive proposals that address operational barriers and comply with new legislative healthcare requirements. This initiative is crucial for improving healthcare access for marginalized populations disproportionately affected by incarceration, with a total funding amount of $106.5 million available for awards ranging from $1 million to $5 million. Interested parties should submit their applications by November 26, 2024, and can direct inquiries to PlanningGrantsPCC@cms.hhs.gov.
    HEAL Initiative: JCOIN Phase II Economic Research Resource Center (U24 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is soliciting applications for the HEAL Initiative: JCOIN Phase II Economic Research Resource Center (U24 Clinical Trial Optional), aimed at addressing substance use disorder (SUD) within the criminal-legal system. This initiative focuses on enhancing research and effective interventions for individuals at risk of overdose during their transition through various stages of the justice system, with an emphasis on increasing access to medication for opioid use disorder (MOUD). The program will support multi-site studies, conduct cost analyses, and develop resources for practitioners, with a total funding amount of $800,000 allocated for one award. Interested applicants must submit their proposals by January 22, 2025, and can direct inquiries to grantsinfo@nih.gov for further information.
    NIDA REI: Research at Minority Serving Institutions on Neurocognitive Mechanisms Underlying the Impact of Structural Racism on the Substance Use Trajectory (R61/R33 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Institute on Drug Abuse (NIDA), has announced a funding opportunity titled "NIDA REI: Research at Minority Serving Institutions on Neurocognitive Mechanisms Underlying the Impact of Structural Racism on the Substance Use Trajectory." This initiative aims to support exploratory research that investigates the neurocognitive effects of structural racism on substance use disorders, particularly within minority-serving institutions, and encourages interdisciplinary approaches to develop preventive strategies against health disparities. The program offers a phased funding mechanism (R61/R33) with a total commitment of $1.5 million annually, aiming to fund 3-5 awards per year, with applications due by November 14, 2024. For further inquiries, applicants can contact the NIH OER Webmaster at OERWebmaster03@od.nih.gov or visit the opportunity's webpage for more details.
    Solutions to enable diagnosis and treatment of adverse health consequences of non-disordered drug use (R41/R42 - Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Institute on Drug Abuse (NIDA), has announced a funding opportunity titled "Solutions to enable diagnosis and treatment of adverse health consequences of non-disordered drug use (R41/R42 - Clinical Trial Optional)." This initiative aims to support Small Business Technology Transfer (STTR) grant applications focused on developing innovative and accessible solutions to improve health outcomes for individuals affected by non-disordered drug use. The program emphasizes the creation of affordable interventions that can be implemented in community-based care systems, targeting vulnerable populations with limited access to traditional healthcare services. Funding amounts of up to $400,000 for Phase I and $3 million for Phase II are available, with applications due by December 3, 2024. Interested applicants can find more information and contact NIH Grants Information at grantsinfo@nih.gov for inquiries.
    NIDA REI: Addressing Racial Equity in Substance Use and Addiction Outcomes Through Community-Engaged Research at Minority Serving Institutions (R01 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Institute on Drug Abuse (NIDA), has announced a funding opportunity titled "NIDA REI: Addressing Racial Equity in Substance Use and Addiction Outcomes Through Community-Engaged Research at Minority Serving Institutions." This initiative invites R01 applications aimed at conducting impactful research to address disparities in substance use and addiction outcomes among racial and ethnic minority populations, emphasizing community engagement and collaboration with community organizations. The program is part of NIDA's broader Racial Equity Initiative, which seeks to improve health equity and reduce health disparities, with approximately $2 million anticipated for funding across multiple related announcements. Interested applicants, particularly from minority-serving institutions, must submit proposals by November 14, 2024, and can reach out to the NIH OER Webmaster at OERWebmaster03@od.nih.gov for further inquiries.
    NCMRR Early Career Research Award (R03 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the NCMRR Early Career Research Award (R03 Clinical Trial Optional) to support early-stage rehabilitation scientists in establishing independent research careers. This grant aims to fund a variety of research projects, including secondary data analysis, methodology development, and translational research, particularly those that can generate preliminary data for future R01 applications. The initiative is crucial for fostering innovative rehabilitation research and enhancing the diversity of research talent in the biomedical field. The maximum funding amount is $200,000 over two years, with applications due by May 8, 2026. Interested applicants can find more information and application details at NIH Grants or contact NIH Grants Information at grantsinfo@nih.gov.
    NIDA REI: Addressing Racial Equity in Substance Use and Addiction Outcomes Through Community-Engaged Research (R01 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "NIDA REI: Addressing Racial Equity in Substance Use and Addiction Outcomes Through Community-Engaged Research," aimed at supporting R01 applications that focus on community-partnered research to mitigate disparities in substance misuse and health outcomes among racial and ethnic minority populations. This initiative emphasizes the establishment of collaborative community partnerships to ensure that research addresses immediate community needs and employs effective methodologies, thereby advancing health equity in the context of substance use and addiction. The program has a budget of approximately $2 million for FY 2023, with applications due by November 14, 2024. Interested applicants can find more information and application instructions at the provided link or contact the NIH OER Webmaster at OERWebmaster03@od.nih.gov for further inquiries.
    Solutions to enable diagnosis and treatment of adverse health consequences of non-disordered drug use (R43/R44 - Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Solutions to enable diagnosis and treatment of adverse health consequences of non-disordered drug use (R43/R44 - Clinical Trial Optional)" aimed at supporting Small Business Innovation Research (SBIR) proposals. This initiative seeks innovative, accessible, and affordable solutions to address health complications arising from non-disordered drug use, including issues such as hypoxia-related brain injuries from opioid overdoses and cardiovascular problems from stimulant use. The program anticipates a total budget of $2 million for approximately 2-5 awards in Fiscal Year 2025, with applications due by December 2, 2024. Interested applicants can find more information and guidelines at the NIH grants website or contact NIH Grants Information at grantsinfo@nih.gov for further inquiries.